Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 6:43 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1129–1152 of 8,689 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Longitudinal Studies Clear all

Conditions: Infertility, Hereditary Diseases
Interventions: Preimplantation Genetic Testing; Other
Lead sponsor: Genomic Prediction Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 500 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2025
U.S. locations: 1
States / cities: North Brunswick, New Jersey

Conditions: Pain
Interventions: OrthoCor Active System; Device
Lead sponsor: Caerus Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 5
States / cities: Gulf Breeze, Florida • Detroit, Michigan • Washington Township, New Jersey + 2 more

Conditions: Kidney Transplantation
Interventions: Rabbit Antithymocyte Globulin, Velcade, Rituxan; Drug
Lead sponsor: University of Cincinnati; Other
Eligibility: 18 Years to 65 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2013
U.S. locations: 2
States / cities: Cincinnati, Ohio

Conditions: Critical Illness, Physiological Stress, Delirium, Sleep Deprivation
Interventions: Sound reduction, Sound masking; Device
Lead sponsor: Brian Gehlbach; Other
Eligibility: 18 Years to 99 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2024
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Moderate to Severe Glabellar Frown Lines
Interventions: IncobotulinumtoxinA (Xeomin) (20 Units), Placebo; Drug
Lead sponsor: Merz Pharmaceuticals GmbH; Industry
Eligibility: 18 Years and older
Enrollment: 271 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 8
States / cities: Englewood, Colorado • Aventura, Florida • Coral Gables, Florida + 5 more

Conditions: Smoking, Tobacco, Fractures, Bone
Interventions: Motivational Interviewing, Motivational Interviewing + Follow-up; Behavioral
Lead sponsor: University of Maryland, Baltimore; Other
Eligibility: 18 Years to 79 Years
Enrollment: 269 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2019
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Bone Marrow Edema
Interventions: Subchondroplasty; Procedure
Lead sponsor: Zimmer Biomet; Industry
Eligibility: 40 Years to 70 Years
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2021
U.S. locations: 6
States / cities: Encinitas, California • New Lenox, Illinois • New York, New York + 3 more

Conditions: Diabetic Kidney Disease, Chronic Kidney Disease Stage 1, Chronic Kidney Disease Stage 2, Chronic Kidney Disease, Stage 3 (Moderate)
Interventions: KidneyIntelX; Diagnostic Test
Lead sponsor: Renalytix AI, Inc.; Industry
Eligibility: 23 Years and older
Enrollment: 2,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Appendix Carcinoma, Carcinomatosis, Colorectal Carcinoma, Gastric Carcinoma, Malignant Peritoneal Neoplasm, Malignant Solid Neoplasm
Interventions: Biospecimen Collection, Pain Assessment, Questionnaire Administration; Procedure · Other
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Elbow Fracture, Range of Motion, Immobilization
Interventions: Splint Immobilization, Early Motion; Other
Lead sponsor: Cooper Norcross Health; Other
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Camden, New Jersey

Conditions: Recurrent Mycosis Fungoides, Recurrent Sezary Syndrome, Refractory Mycosis Fungoides, Refractory Sezary Syndrome, Stage IB Mycosis Fungoides and Sezary Syndrome AJCC v8, Stage IIA Mycosis Fungoides and Sezary Syndrome AJCC v8, Stage IIB Mycosis Fungoides and Sezary Syndrome AJCC v8, Stage III Mycosis Fungoides and Sezary Syndrome AJCC v8, Stage IV Mycosis Fungoides and Sezary Syndrome AJCC v8
Interventions: Non-Interventional Study; Other
Lead sponsor: City of Hope Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 10
States / cities: Duarte, California • Palo Alto, California • Tampa, Florida + 7 more

Conditions: Open Midline Laparotomy
Interventions: Phasix™ Mesh; Device
Lead sponsor: C. R. Bard; Industry
Eligibility: 18 Years and older
Enrollment: 477 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2031
U.S. locations: 20
States / cities: Phoenix, Arizona • San Francisco, California • Hartford, Connecticut + 17 more

Conditions: Depression
Interventions: PEER Interactive Report; Device
Lead sponsor: MYnd Analytics; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 468 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2016
U.S. locations: 1
States / cities: Raleigh, North Carolina

Conditions: Degenerative Arthritis, Rheumatoid Arthritis, Post Traumatic Arthritis
Interventions: Zimmer Trabecular Metal Total Ankle System; Device
Lead sponsor: Zimmer Biomet; Industry
Eligibility: 18 Years and older
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2027
U.S. locations: 5
States / cities: Sacramento, California • Grand Rapids, Michigan • Charlotte, North Carolina + 2 more

Conditions: Myopia
Interventions: LASIK, PRK, Small target contrast sensitivity and disability glare; Procedure · Behavioral
Lead sponsor: Walter Reed Army Medical Center; Federal
Eligibility: 21 Years and older
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: GastroIntestinal Bleeding
Interventions: Not listed
Lead sponsor: Xingshun Qi; Other
Eligibility: 18 Years and older
Enrollment: 3,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Scranton, Pennsylvania

Conditions: Diabetic Macular Edema
Interventions: Ozurdex, Eylea; Drug
Lead sponsor: Texas Retina Associates; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Coronary Heart Disease, Biomarkers of Cardiovascular Disease
Interventions: Dr. Dean Ornish Program for Reversing Heart Disease; Behavioral
Lead sponsor: Preventive Medicine Research Institute; Other
Eligibility: 21 Years and older
Enrollment: 131 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2009
U.S. locations: 1
States / cities: Sausalito, California

Conditions: Hemophilia A, Hemophilia B
Interventions: Counseling, Control; Behavioral
Lead sponsor: New York Presbyterian Hospital; Other
Eligibility: 12 Years to 20 Years · Male only
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2008
U.S. locations: 1
States / cities: New York, New York

Conditions: Carpal Tunnel Syndrome, CTS
Interventions: Carpal Tunnel Release with Ultrasound Guidance using the UltraGuideCTR device; Device
Lead sponsor: Sonex Health, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 149 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 7
States / cities: Fort Walton Beach, Florida • Vero Beach, Florida • Atlanta, Georgia + 4 more

Conditions: Cystic Fibrosis
Interventions: Nitric Oxide 160 ppm; Drug
Lead sponsor: Novoteris, LLC; Industry
Eligibility: 18 Years and older
Enrollment: 49 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 6
States / cities: Garden Grove, California • Los Angeles, California • Columbus, Ohio + 3 more

Conditions: Pancreaticoduodenectomy
Interventions: robotic pancreaticoduodenectomy; Procedure
Lead sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Other
Eligibility: 18 Years and older
Enrollment: 91 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2025
U.S. locations: 2
States / cities: Baltimore, Maryland • Charlotte, North Carolina

Conditions: Elbow, Tennis
Interventions: TenJet System; Device
Lead sponsor: HydroCision, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 3
States / cities: Muskegon, Michigan • DuBois, Pennsylvania • Fort Worth, Texas

Conditions: Abdominal Aortic Aneurysms
Interventions: UniFit AAA Stent Graft; Device
Lead sponsor: Duke Vascular, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 71 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2015
U.S. locations: 19
States / cities: Loma Linda, California • Torrance, California • Newark, Delaware + 16 more

Search by objective public record fields.

Embryo Health Study

Study to Evaluate the OrthoCor Active System for Pain Relief

Randomized Trial of Induction Therapies in High Immunological Risk Kidney Transplant Recipients

Trial to Evaluate the Effects of Sound Modulation on Critically Ill Patients

IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Glabellar Frown Lines

Let's STOP Now Trial: Smoking in Trauma Orthopaedic Patients

Evaluation of Subchondroplasty™ for Defects Associated With Bone Marrow Lesions

Prospective Decision Impact Trial of KidneyIntelX

Psychological, Psychophysical and Epigenetic Determinants of Chronic Pain After Cytoreductive - Hyperthermic Intraoperative Chemotherapy

Does Early Elbow Motion Improve Patient Outcomes After Surgically Treated Elbow Fractures?

A Prospective, US-based Study Assessing Mogamulizumab-associated Rash in Patients Diagnosed With Mycosis Fungoides or Sezary Syndrome and Treated With Standard of Care Mogamulizumab

Prophylactic Reinforcement of Ventral Abdominal Incisions Trial

Study to Evaluate the Safety and Efficacy of PEER Interactive to Inform Medication Prescription for Subjects With a Primary Diagnosis of Depression

Zimmer Trabecular Metal Total Ankle PMCF

A Prospective Evaluation of Contrast Sensitivity and Disability Glare in Refractive Surgery, a Sub-Study of: Initial Evaluation of Excimer Laser Keratorefractive Surgery in U.S. Army Personnel (WU # 2335-99)

Validation of CAGIB Score for In-hospital Mortality of Cirrhotic Patients With Acute Gastrointestinal Bleeding

One Year Trial Evaluating Safety of Ozurdex With Eylea

A Prospective Evaluation of Health Services Outcomes and Emerging Cardiovascular Disease Biomarkers

The Effect of Patient Counseling on Adolescent Hemophilia Patient Compliance With Bleeding Logs

Multicenter Prospective Trial of Office-based Carpal Tunnel Release With Ultrasound Guidance (ROBUST)

Efficacy and Safety of Inhaled Nitric Oxide (NO) in Cystic Fibrosis (CF) Patients

Observation of Perioperative Outcomes of Robotic Pancreaticoduodenectomy

Percutaneous US Guided Elbow Tenotomy With the TenJet HydroSurgery System

Safety Study for the Treatment of Abdominal Aortic Aneurysms